Previous 10 | Next 10 |
Guardion Health Sciences, Inc. ( GHSI ) increased 94% to $1.86 and hit as high as $3.05 on Wednesday on over 30 million shares traded after announcing that its proprietary medical device, the MapcatSF®, received a patent from the Hong Kong Patents Registry. The patent was granted specif...
Jaguar Health (NASDAQ: JAGX ) -31% . More news on: Jaguar Health, Inc., J. C. Penney Company, Inc., Marker Therapeutics, Inc., Stocks on the move, Read more ...
American Electric Technologies (NASDAQ: AETI ) -39% after stockholders approved share exchange transaction with Stabilis Energy. More news on: American Electric Technologies, Inc, Senseonics Holdings, Inc., Netflix, Inc., Stocks on the move, Read more ...
July 18, 2019 Palm Beach, FL –July 18, 2019 – Acute myeloid leukemia (AML) is a cancer that is rarely seen before age 45 with the average age of onset around 65. It is the most common of the four major types of leukemia. Without treatment, AML is often deadly wi...
San Diego, CA, July 17, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced that it has received a patent from the Patents Registry in Hong Kong (Hong Kong Patent No. HK1204758 titled “Apparatus f...
Guardion Health Sciences (NASDAQ: GHSI ) +35% on receiving a patent from the European Union for its proprietary medical device, the MapcatSF. More news on: Guardion Health Sciences, Inc., DiaMedica Therapeutics Inc., Melinta Therapeutics, Inc., Stocks on the move, Read more .....
San Diego, CA, June 20, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences and technologies company that develops, formulates and distributes condition-specific medical foods and testing...
In an IRB-approved trial conducted at the New York Eye and Ear Infirmary, the parent compound of GlaucoCetin, GlaucoHealth, designed by Robert Ritch, MD, successfully reversed mitochondrial dysfunction in patients with glaucoma. San Diego, CA, June 04, 2019 (GLOBE NEWSWIRE) -- Gu...
In a recent study presented at the Association for Research in Vision and Ophthalmology (ARVO) 2019 annual meeting, improvements in visual function (CSF) in the Lumega-Z Group were statistically significant and definitive. The AREDS 2 Group showed no statistical change. San Diego, CA, ...
Biotech Stocks: Global Revenues For Ophthalmology Market Projected To Reach $26 Billion By 2022 May 9, 2019 Palm Beach, FL –May 9, 2019 – As the baby boomer generation ages, there is an increased need… no… a demand by these aging patients to avert vision and...
News, Short Squeeze, Breakout and More Instantly...
Guardion Health Sciences Inc. Company Name:
GHSI Stock Symbol:
NASDAQ Market:
Guardion Health Sciences Inc. Website:
2024-07-21 23:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-11 20:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of co...